R
Roland E. Schmieder
Researcher at University of Erlangen-Nuremberg
Publications - 780
Citations - 85811
Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.
Papers
More filters
Journal ArticleDOI
Effects of angiotensin II type 1-receptor blockade on retinal endothelial function.
Christian Ott,Markus P. Schlaich,Joanna Harazny,Bernhard Schmidt,Georg Michelson,Roland E. Schmieder +5 more
TL;DR: AT1-receptor blockade with irbesartan improves endothelial function of the retinal vasculature, taken as a model of cerebral circulation, in normocholesterolemic and hypercholesterolesmic subjects.
Journal ArticleDOI
Efficacy, safety and tolerability of valsartan 80 mg compared to irbesartan 150 mg in hypertensive patients on long-term hemodialysis (VALID study).
TL;DR: Valsartan 80 mg is as effective, safe and well tolerated as irbesartan 150 mg in hypertensive patients on chronic hemodialysis in patients with arterial hypertension on long-term heModialysis.
Journal ArticleDOI
Circadian rhythm and day to day variability of serum potassium concentration: a pilot study.
S. Schmidt,T. Ditting,B. Deutsch,R. Schutte,S. Friedrich,Iris Kistner,Christian Ott,Ulrike Raff,R. Veelken,Roland E. Schmieder +9 more
TL;DR: It is indicated that patients with normal and impaired RF have comparable circadian patterns of serum potassium concentrations, but higher fluctuations in patients with impaired RF, which has clinical relevance for developing an automatic biosensor to measure the potassium concentration in blood under ambulatory conditions in patients at high risk for potassium fluctuations.
Journal ArticleDOI
Kommentar zur 2013-ESH/ESC-Leitlinie zum Management der arteriellen Hypertonie
Ulrich Kintscher,Michael Böhm,F. Goss,Rainer Kolloch,Reinhold Kreutz,Roland E. Schmieder,Heribert Schunkert +6 more
TL;DR: The DHL/DGK pocket guidelines represent an exact translation of the ESH/ESC pocket guidelines and are intended to inform clinicians about important changes in the new guidelines.
Journal ArticleDOI
Ruling out secondary causes of hypertension
TL;DR: If appropriately diagnosed and treated, patients with a secondary form of hypertension might be cured, or at least show an improvement in their blood pressure control, and screening for secondary causes of hypertension plays an essential part in the care of patients with arterial hypertension.